SCHEMBL25635341

SCHEMBL25635341

c1ccc2c(c1)c1cccn1c1cccn1c1cccn21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
ALDH1A1 P00352 5/20 0.35
KDM4E B2RXH2 4/20 0.35
PTPN1 P18031 2/20 0.35
RXFP1 Q9HBX9 2/20 0.35
HSD17B10 Q99714 2/20 0.35
HPGD P15428 2/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
PARP1 P09874 1/20 0.35
PTPN2 P17706 1/20 0.35
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MAPT P10636 2/20 0.33
GPR84 Q9NQS5 1/20 0.33
NQO2 P16083 1/20 0.32
CYP2A6 P11509 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25634885 0.91 GPR3 (0.42) GPR3CYP1A2CYP2C19ALDH1A1KDM4E
SCHEMBL25634891 0.82 ALDH1A1 (0.43) ALDH1A1KDM4EPTPN1RXFP1HSD17B10
SCHEMBL25634893 0.79 ALDH1A1 (0.33) ALDH1A1KDM4EPTPN1RXFP1HSD17B10
SCHEMBL12092119 0.77 GPR3 (0.48) GPR3CYP1A2CYP2C19ALDH1A1KDM4E
SCHEMBL25634887 0.77 GPR3 (0.48) GPR3CYP1A2CYP2C19ALDH1A1KDM4E
SCHEMBL17809837 0.76 KDM4E (0.41) GPR3CYP1A2CYP2C19ALDH1A1KDM4E
SCHEMBL22045983 0.72 PGR (0.53) CYP1A2CYP2C19ALDH1A1KDM4EHSD17B10
SCHEMBL12859617 0.71 GPR3 (0.42) GPR3CYP1A2CYP2C19ALDH1A1KDM4E
SCHEMBL19054129 0.70 ALDH1A1 (0.34) CYP1A2ALDH1A1KDM4EPTPN1RXFP1
SCHEMBL19054481 0.70 GPR3 (0.41) GPR3ALDH1A1KDM4EPTPN1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192714-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192714-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, ODC1 GPR3 1340/4885CYP1A2 314/4885CYP2C19 125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.